MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
5.45 M |
Marktkapitalisierung |
$ 8.72 M |
EBITDA (LTM) |
$ -10.3 M |
P/E (LTM) |
-1.384181 |
P/S (LTM) |
6.753624 |
EPS (LTM) |
-1.77 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
AbbVie
ABBV
|
$ 284.8 | -1.45 % | $ 504 B | NYSE,SPB | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 31.87 | -2.89 % | $ 4.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Altimmune
ALT
|
$ 2.23 | -3.04 % | $ 196 M | Nasdaq Global Market | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.18 | -3.46 % | $ 801 M | Nasdaq Global Select Market |  Canada |
 |
Axon Enterprise
AXON
|
$ 402.6 | 2.54 % | $ 31.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Oncternal Therapeutics
ONCT
|
- | -24.12 % | $ 1.56 M | Nasdaq Capital Market | USA |
 |
Black Diamond Therapeutics
BDTX
|
$ 2.08 | 0.48 % | $ 118 M | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 3.05 | -0.65 % | $ 668 M | NYSE |  Britain |
 |
Catalyst Biosciences
CBIO
|
$ 13.17 | 0.77 % | $ 1.18 B | Nasdaq Capital Market | USA |
 |
Seagen
SGEN
|
- | - | $ 42.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Codexis
CDXS
|
$ 1.29 | 4.88 % | $ 112 M | Nasdaq Global Select Market | USA |
 |
Cullinan Management
CGEM
|
$ 14.89 | 0.4 % | $ 897 M | Nasdaq Global Select Market | USA |
 |
Compugen Ltd.
CGEN
|
$ 2.12 | -0.93 % | $ 198 M | Nasdaq Global Market,SPB |  Israel |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Aclaris Therapeutics
ACRS
|
$ 3.81 | 1.06 % | $ 467 M | Nasdaq Global Select Market | USA |
 |
Cellectar Biosciences
CLRB
|
$ 1.28 | 4.07 % | $ 3.34 M | Nasdaq Capital Market | USA |
 |
Cocrystal Pharma
COCP
|
$ 0.96 | 1.81 % | $ 10.8 M | Nasdaq Capital Market | USA |
 |
Collegium Pharmaceutical
COLL
|
$ 22.92 | -1.36 % | $ 725 M | Nasdaq Global Select Market | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
$ 4.29 | -3.05 % | $ 57.1 M | Nasdaq Global Market | USA |
 |
Vascular Biogenics Ltd.
VBLT
|
- | -8.77 % | $ 12.4 M | Nasdaq Global Select Market | Israel |
 |
Curis
CRIS
|
$ 0.39 | -1.9 % | $ 5.13 M | Nasdaq Global Market | USA |
 |
Berkeley Lights
BLI
|
- | -7.31 % | $ 87 M | Nasdaq Global Select Market | USA |
 |
Corvus Pharmaceuticals
CRVS
|
$ 10.05 | -1.76 % | $ 794 M | Nasdaq Global Market | USA |
 |
Histogen
HSTO
|
- | 31.6 % | $ 2.12 M | Nasdaq Global Select Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 25.33 | 3.73 % | $ 3.84 B | Nasdaq Global Select Market,SPB | USA |
 |
Achieve Life Sciences
ACHV
|
$ 6.51 | 1.31 % | $ 284 M | Nasdaq Capital Market | USA |
 |
ImmunoGen
IMGN
|
- | - | $ 7.92 B | Nasdaq Global Select Market | USA |
 |
Denali Therapeutics
DNLI
|
$ 18.68 | -1.32 % | $ 3.23 B | Nasdaq Global Select Market,SPB | USA |
 |
Precision BioSciences
DTIL
|
$ 6.71 | 2.29 % | $ 86.1 M | Nasdaq Global Select Market | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 37.18 | 1.47 % | $ 2.16 B | Nasdaq Global Select Market,SPB | USA |
 |
Editas Medicine
EDIT
|
$ 2.51 | -2.71 % | $ 223 M | Nasdaq Global Select Market,SPB | USA |
 |
Enanta Pharmaceuticals
ENTA
|
$ 11.31 | -3.08 % | $ 241 K | Nasdaq Global Select Market,SPB | USA |
 |
AIM ImmunoTech
AIM
|
$ 0.17 | 1.25 % | $ 275 K | NYSE American | USA |
 |
Exelixis
EXEL
|
$ 64.58 | 0.3 % | $ 17.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | USA |
 |
Fortress Biotech
FBIO
|
$ 1.94 | -0.26 % | $ 54.1 M | Nasdaq Capital Market | USA |
 |
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market |  Irlanda |
 |
Akebia Therapeutics
AKBA
|
$ 0.59 | -5.31 % | $ 152 M | Nasdaq Global Market | USA |
 |
Galectin Therapeutics
GALT
|
$ 3.37 | -1.75 % | $ 215 M | Nasdaq Global Select Market | USA |
 |
GeoVax Labs
GOVX
|
$ 0.23 | 2.25 % | $ 220 K | Nasdaq Global Select Market | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 8.76 | -5.71 % | $ 590 B | Nasdaq Capital Market | Britain |
 |
Clovis Oncology
CLVS
|
- | -7.23 % | $ 13 M | Nasdaq Global Select Market | USA |
 |
GlaxoSmithKline plc
GSK
|
$ 50.02 | -1.2 % | $ 203 B | NYSE | Britain |
 |
GT Biopharma
GTBP
|
$ 5.41 | -25.99 % | $ 29.8 M | Nasdaq Capital Market | USA |
 |
Amarin Corporation plc
AMRN
|
$ 11.51 | 0.26 % | $ 4.78 B | Nasdaq Global Market | Irlanda |
 |
Aldeyra Therapeutics
ALDX
|
$ 0.67 | -8.72 % | $ 40.2 M | Nasdaq Global Select Market | USA |
 |
Concert Pharmaceuticals
CNCE
|
- | - | $ 401 M | Nasdaq Global Market | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
- | - | $ 231 M | Nasdaq Global Market | USA |